You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.
NEW YORK (GenomeWeb) – Veracyte said today that 10 new Blue Cross Blue Shield plans recently issued positive coverage decisions for its Afirma Gene Expression Classifier for use in thyroid cancer diagnosis.
...and receive Daily News bulletins.
Already have a 360Dx or GenomeWeb account?Login Now.
Don't have a 360Dx or GenomeWeb account?Register for Free.